Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mechano Therapeutics LLC, Philadelphia, Pennsylvania, USA.
J Orthop Res. 2024 Jul;42(7):1409-1419. doi: 10.1002/jor.25813. Epub 2024 Feb 18.
Mucopolysaccharidosis (MPS) I is a lysosomal storage disorder characterized by deficient alpha-l-iduronidase activity, leading to abnormal accumulation of glycosaminoglycans (GAGs) in cells and tissues. Synovial joint disease is prevalent and significantly reduces patient quality of life. There is a strong clinical need for improved treatment approaches that specifically target joint tissues; however, their development is hampered by poor understanding of underlying disease pathophysiology, including how pathological changes to component tissues contribute to overall joint dysfunction. Ligaments and tendons, in particular, have received very little attention, despite the critical roles of these tissues in joint stability and biomechanical function. The goal of this study was to leverage the naturally canine model to undertake functional and structural assessments of the anterior (cranial) cruciate ligament (CCL) and Achilles tendon in MPS I. Tissues were obtained postmortem from 12-month-old MPS I and control dogs and tested to failure in uniaxial tension. Both CCLs and Achilles tendons from MPS I animals exhibited significantly lower stiffness and failure properties compared to those from healthy controls. Histological examination revealed multiple pathological abnormalities, including collagen fiber disorganization, increased cellularity and vascularity, and elevated GAG content in both tissues. Clinically, animals exhibited mobility deficits, including abnormal gait, which was associated with hyperextensibility of the stifle and hock joints. These findings demonstrate that pathological changes to both ligaments and tendons contribute to abnormal joint function in MPS I, and suggest that effective clinical management of joint disease in patients should incorporate treatments targeting these tissues.
黏多糖贮积症(MPS)I 是一种溶酶体贮积病,其特征是缺乏α-L-艾杜糖苷酸酶活性,导致细胞和组织中糖胺聚糖(GAG)异常积聚。滑膜关节疾病很常见,严重降低了患者的生活质量。因此,人们非常需要改进的治疗方法,这些方法特别针对关节组织;然而,由于对潜在疾病病理生理学的理解不足,包括病理变化如何导致整体关节功能障碍,这些方法的开发受到了阻碍。韧带和肌腱,特别是,尽管这些组织在关节稳定性和生物力学功能中起着至关重要的作用,但它们受到的关注非常少。本研究的目的是利用自然犬模型对 MPS I 中的前十字韧带(CCL)和跟腱进行功能和结构评估。从 12 个月大的 MPS I 和对照犬死后获得组织,并在单轴张力下进行失效测试。与健康对照组相比,MPS I 动物的 CCL 和跟腱的刚度和失效特性明显较低。组织学检查显示出多种病理异常,包括胶原纤维紊乱、细胞和血管增多以及两种组织中 GAG 含量升高。临床上,动物表现出运动功能障碍,包括异常步态,这与膝关节和跗关节过度伸展有关。这些发现表明,韧带和肌腱的病理变化导致 MPS I 中关节功能异常,并表明在治疗患者的关节疾病时,应将针对这些组织的治疗纳入临床管理中。